Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-α Results in the Activation of Specific CD8+ T Cells and Monocyte/Dendritic Cell Precursors-Reference-Cited by-同舟云学术

Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-α Results in the Activation of Specific CD8+ T Cells and Monocyte/Dendritic Cell Precursors

Published:2006-05-01 Issue:9 Volume:66 Page:4943-4951
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Di Pucchio Tiziana,Pilla Lorenzo,Capone Imerio,Ferrantini Maria,Montefiore Enrica,Urbani Francesca,Patuzzo Roberto,Pennacchioli Elisabetta,Santinami Mario,Cova Agata,Sovena Gloria,Arienti Flavio,Lombardo Claudia,Lombardi Arianna,Caporaso Patrizia,D'Atri Stefania,Marchetti Paolo,Bonmassar Enzo,Parmiani Giorgio,Belardelli Filippo,Rivoltini Licia

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional Heterogeneity of Umbilical Cord Blood Monocyte-Derived Dendritic Cells;The Journal of Immunology;2024-05-29

2. DNA Damage-driven Inflammatory Cytokines: Reprogramming of Tumor Immune Microenvironment and Application of Oncotherapy;Current Medical Science;2024-04

3. Cytokines and their role as immunotherapeutics and vaccine Adjuvants: The emerging concepts;Cytokine;2023-09

4. Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alpha;Frontiers in Oncology;2023-05-18

5. Type I and II interferons toward ideal vaccine and immunotherapy;Expert Review of Vaccines;2021-05-04